4-76181015-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000264896.8(SCARB2):​c.362G>A​(p.Arg121Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,613,624 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00057 ( 7 hom. )

Consequence

SCARB2
ENST00000264896.8 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0100
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027380884).
BP6
Variant 4-76181015-C-T is Benign according to our data. Variant chr4-76181015-C-T is described in ClinVar as [Benign]. Clinvar id is 138967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0058 (883/152196) while in subpopulation AFR AF= 0.0193 (802/41526). AF 95% confidence interval is 0.0182. There are 8 homozygotes in gnomad4. There are 421 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCARB2NM_005506.4 linkuse as main transcriptc.362G>A p.Arg121Gln missense_variant 3/12 ENST00000264896.8 NP_005497.1
SCARB2XM_047416429.1 linkuse as main transcriptc.-113G>A 5_prime_UTR_variant 3/12 XP_047272385.1
SCARB2XM_047416430.1 linkuse as main transcriptc.-113G>A 5_prime_UTR_variant 3/12 XP_047272386.1
SCARB2NM_001204255.2 linkuse as main transcriptc.276-5105G>A intron_variant NP_001191184.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCARB2ENST00000264896.8 linkuse as main transcriptc.362G>A p.Arg121Gln missense_variant 3/121 NM_005506.4 ENSP00000264896 P4Q14108-1
ENST00000651366.1 linkuse as main transcriptn.103-18951C>T intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.00581
AC:
883
AN:
152078
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00426
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00147
AC:
369
AN:
251100
Hom.:
2
AF XY:
0.00111
AC XY:
151
AN XY:
135724
show subpopulations
Gnomad AFR exome
AF:
0.0198
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000573
AC:
837
AN:
1461428
Hom.:
7
Cov.:
30
AF XY:
0.000506
AC XY:
368
AN XY:
727032
show subpopulations
Gnomad4 AFR exome
AF:
0.0199
Gnomad4 AMR exome
AF:
0.00159
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000899
Gnomad4 OTH exome
AF:
0.00133
GnomAD4 genome
AF:
0.00580
AC:
883
AN:
152196
Hom.:
8
Cov.:
32
AF XY:
0.00566
AC XY:
421
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.0193
Gnomad4 AMR
AF:
0.00425
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00114
Hom.:
2
Bravo
AF:
0.00692
ESP6500AA
AF:
0.0204
AC:
90
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00189
AC:
229
Asia WGS
AF:
0.00144
AC:
5
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 12, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 19, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJan 12, 2017- -
Progressive myoclonic epilepsy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.16
T;.;.;.;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.12
N
LIST_S2
Uncertain
0.86
D;D;D;D;D
MetaRNN
Benign
0.0027
T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.9
L;.;.;.;.
MutationTaster
Benign
0.97
D;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.0
N;.;.;.;.
REVEL
Benign
0.12
Sift
Benign
0.26
T;.;.;.;.
Sift4G
Benign
0.28
T;.;.;.;.
Polyphen
0.13
B;.;.;.;.
Vest4
0.19
MVP
0.75
MPC
0.34
ClinPred
0.013
T
GERP RS
4.2
Varity_R
0.27
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73826386; hg19: chr4-77102168; COSMIC: COSV53668756; COSMIC: COSV53668756; API